BXP price target lowered to $67 from $75 at Truist

Truist analyst Michael Lewis lowered the firm’s price target on BXP to $67 from $75 and keeps a Hold rating on the shares. The firm is adjusting its model to reflect a more conservative occupancy recovery projection, the analyst tells investors in a research note. While BXP offers a high-quality portfolio/platform and the stock has pulled back, there is currently even more value in deeply discounted office REITs that are also nearing occupancy, Truist added.